| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Financial Officer
1 company
Estepan Ian Michael is a Chief Operating Officer at Sarepta Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | SRPT Sarepta Therapeutics, Inc. | Chief Operating Officer | Sell | 13,187 | $22.31 | $294,201.97 | -6.4% | -25.3% | - | |
| Aug 30, 2024 | SRPT Sarepta Therapeutics, Inc. | Chief Financial Officer | Sell | 5,985 | $137.36 | $822,099.60 | -15.0% | -1.8% | -86.6% | |
| Mar 1, 2024 | SRPT Sarepta Therapeutics, Inc. | Chief Financial Officer | Sell | 1,200 | $128.30 | $153,960.00 | -3.0% | -3.3% | -17.0% |